Table 1 |
||||||
|
Measured variables of participants classified as current smokers (CS), ex-smokers (XS), and never-smokers (NS) |
||||||
|
Gender |
Male (n = 102) |
Female (n = 290) |
||||
|
|
||||||
|
Smoking status |
CS |
XS |
NS |
CS |
XS |
NS |
|
|
||||||
|
Number |
20 |
50 |
32 |
49 |
97 |
144 |
|
Age, years |
58.8 ± 8.1a |
65.2 ± 9.9b |
58.8 ± 15 |
57.4 ± 13.3a |
64.1 ± 11.2b |
60.7 ± 11.8 |
|
Height, cm |
171.3 ± 7.1 |
174.3 ± 6.9 |
172.7 ± 7.7 |
160.9 ± 6.9 |
160.8 ± 6.8 |
159.5 ± 6.8 |
|
Weight, kg |
76 ± 12.9b, c |
85.8 ± 13.6 |
84.1 ± 14.8 |
67.5 ± 14.2a |
74.8 ± 15.2 |
69.9 ± 13.6 |
|
Body mass index, kg/m2 |
25.8 ± 3.3b, c |
28.4 ± 3.8 |
27.6 ± 4.6 |
26.1 ± 5.5a, b |
28.6 ± 5.4 |
27.5 ± 5 |
|
Body fat, percentage |
24.5 ± 6.4c, d |
28.8 ± 6.8 |
27.8 ± 5.6 |
35.9 ± 7a, b |
39.2 ± 6.5 |
38.1 ± 6.7 |
|
Fat-free mass, kg |
57.2 ± 9.4 |
61.7 ± 7.7 |
59.8 ± 10.3 |
42.5 ± 4.8 |
43.7 ± 6.1 |
42.5 ± 6.1 |
|
Waist circumference, cm |
100 ± 7.9c |
106.2 ± 10.8b |
102.9 ± 9.3 |
90.8 ± 12.8a |
98.6 ± 13 |
94.7 ± 12.7 |
|
ESR, mm/hour |
26.5 ± 20.5 |
22.8 ± 21.3 |
20.7 ± 19.7 |
30.5 ± 26 |
34.3 ± 32.7b |
25.5 ± 19.8 |
|
C-reactive protein, mg/L |
13.3 ± 9.4 |
16.1 ± 20.4 |
16 ± 24.3 |
21.9 ± 23.2b |
21.4 ± 32.7b |
11.9 ± 12.5 |
|
DAS28 |
4 ± 0.9 |
4.1 ± 1.5 |
3.9 ± 1.6 |
4.5 ± 1.5 |
4.3 ± 1.5 |
4.1 ± 1.2 |
|
HAQ score |
0.9 ± 0.8 |
1.4 ± 1 |
1.1 ± 0.9 |
1.5 ± 0.9 |
1.5 ± 0.9 |
1.5 ± 0.9 |
|
Disease duration, years |
8.6 ± 7.8 |
11.9 ± 10.6 |
14.6 ± 12.7 |
11.4 ± 9.8 |
13.5 ± 10.8 |
13.5 ± 11.1 |
|
|
||||||
|
Values are presented as mean ± standard deviation. aSignificant difference compared with XS (P < 0.05). bSignificant difference compared with NS (P < 0.05). cSignificant difference compared with XS (P < 0.001). dSignificant difference compared with NS (P < 0.001). DAS28, Disease Activity Score-28; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire. |
||||||
|
Stavropoulos-Kalinoglou et al. Arthritis Research & Therapy 2008 10:R59 doi:10.1186/ar2429 |
||||||